Signature Wealth Management Partners’s Transmedics TMDX Stock Holding History

Signature Wealth Management Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,200	Closed	-$444K	–	111
2022 Q4	$444K	Hold	7,200	–	–	0.44%	57
2022 Q3	$301K	Sell	7,200 -5,000	-41%	-$217K	0.33%	70
2022 Q2	$384K	Hold	12,200	–	–	0.39%	65
2022 Q1	$329K	Buy	+12,200	New	+$219K	0.28%	76
2021 Q4	–	Sell	-14,000	Closed	-$463K	–	115
2021 Q3	$463K	Hold	14,000	–	–	0.42%	62
2021 Q2	$465K	Hold	14,000	–	–	0.42%	59
2021 Q1	$581K	Buy	+14,000	New	+$431K	0.56%	51

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

Signature Wealth Management Partners's TMDX Position: Q1 2023 in Review

Signature Wealth Management Partners sold out of Transmedics (TMDX) in Q1 2023, closing a stake of 7,200 shares — an estimated $444K sold.

Signature Wealth Management Partners first reported a position in TMDX in Q1 2021 and held it in 7 quarters. The position peaked at $581K in Q1 2021. 224 funds tracked by Wall St. Rank hold TMDX as of Q1 2023.

Signature Wealth Management Partners reported no remaining Transmedics position as of Q1 2023 after selling out during the quarter.
Signature Wealth Management Partners sold 7,200 Transmedics shares in Q1 2023, an estimated $444K.
Signature Wealth Management Partners first reported a position in Transmedics in Q1 2021 and held it in 7 quarters.
Signature Wealth Management Partners's Transmedics position peaked at $581K in Q1 2021.
224 funds tracked by Wall St. Rank held Transmedics as of Q1 2023.

Based on Signature Wealth Management Partners's 13F filing for Q1 2023, filed 3 May 2023.